ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.74
-1.19%
US Tech 100
19,052.00
-0.09%
S&P 500
5,433.74
0.23%
US Dollar vs CAD
1.37591
0.11%
Bitcoin
66,909.71
0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) News

FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FOLD
DateTimeSourceHeadlineSymbolCompany
06/07/20246:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20246:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20243:38PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FOLDAmicus Therapeutics Inc
06/07/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
06/05/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/05/20246:00AMGlobeNewswire Inc.Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
05/09/20243:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FOLDAmicus Therapeutics Inc
05/09/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
05/09/20246:00AMGlobeNewswire Inc.Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
05/08/20246:00AMGlobeNewswire Inc.Amicus Therapeutics to Present at the Bank of America 2024 Health Care ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
05/01/20246:00AMGlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:FOLDAmicus Therapeutics Inc
03/20/20246:00AMGlobeNewswire Inc.Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) ReportNASDAQ:FOLDAmicus Therapeutics Inc
03/11/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/06/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/05/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/05/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/05/20243:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/04/20244:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/01/20243:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/01/20243:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
03/01/20246:00AMGlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024NASDAQ:FOLDAmicus Therapeutics Inc
02/28/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
02/28/20246:00AMGlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
02/20/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Your Recent History

USOTC
QSEP
QS Energy (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
NLST
Netlist (QB)
USOTC
MWWC
Marketing Worldwide (PK)
NASDAQ
TSLA
Tesla
USOTC
PHIL
PHI (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
RDGL
Vivos (QB)
USOTC
PPCB
Propanc Biopharma (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
CYDY
CytoDyn (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved